IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

935.00

Prev. Close

923.80

Turnover (lac.)

147,336

Day's High

1,023.70

Day's Low

932.00

52 Week's High

1,023.70

52 Week's Low

288.85

Book Value

248

Face Value

1

Mkt Cap (Cr.)

58,512

P/E

21.98

EPS

45.4

Divi. Yield

0.3

Aurobindo Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Aurobindo Pharma LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd586.4048.84140,732.99724.810.683,207.24106.10
Divis Laboratories Ltd3,569.0553.9294,793.52513.300.451,713.78313.47
Dr Reddys Laboratories Ltd5,082.4034.4284,514.47481.000.493,333.60979.38
Cipla Ltd836.8030.1067,508.80745.640.483,711.03233.61
Aurobindo Pharma Ltd998.6021.9858,476.67801.540.304,425.43246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Aurobindo Pharma LtdSummary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by aurobindo-pharma-ltd-share-price

View

- <

Reco. Price

Jan 25,2021 03:29 PM

Target Price

Target Returns:

0.00%

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Jan 26, 2021 03:31 PM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    11 Nov 2020

    Effective. Date

    23 Nov 2020

    Divi. Type

    Interim 2

    Divi.(%)

    125

    Divi. Amt.

    1.25

    The Board of Directors of the Company at its meeting held today, November 11, 2020, has, inter alia,... More

  • Purpose

    Board Meeting

    Exp. Date

    11 Nov 2020

    Annc. Date

    02 Nov 2020

    AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is s... More

  • Purpose

    AGM

    Exp. Date

    27 Aug 2020

    Annc. Date

    03 Aug 2020

    AGM 27/08/2020We hereby inform that the 33rd Annual General Meeting of the Company is scheduled to b... More